• Explore /
  • Poster
  • / The prognostic impact of immune-related adverse events in real-world patients with metastatic melanoma treated with single-agent and combination immune checkpoint blockade.

The prognostic impact of immune-related adverse events in real-world patients with metastatic melanoma treated with single-agent and combination immune checkpoint blockade.

Abstract Poster

Authors

Alexander Watson

Alexander Watson

Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada

Alexander Watson , Siddhartha Goutam , Igor Stukalin , Benjamin Ewanchuk , Michael Sander , Daniel E. Meyers , Aliyah Pabani , Winson Y. Cheung , Daniel Yick Chin Heng , Tina Cheng , Jose Gerard Monzon , Vishal Navani

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Advanced/Metastatic Disease

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 9542)

DOI

10.1200/JCO.2022.40.16_suppl.9542

Abstract #

9542

Poster Bd #

135

Abstract Disclosures

Similar Posters

First Author: Olisaemeka Ogbue

First Author: Lorenzo Pilla

First Author: Esmail Mutahar Al-Ezzi

First Author: Talal El Zarif